Determine efficacy of immunotherapy in PD-L1 negative and low patients: CDSCO Panel Tells Dr Reddy on Nivolumab Dr. Divya Colin20 Jan 2024 5:30 PM ISTNew Delhi: Based on the Phase I/III clinical trial protocol of the anti-cancer drug Nivolumab presented by the drug major Dr Reddy Laboratories, the...
Havisure: India's first indigenously developed Hepatitis A vaccine launched Ruchika Sharma20 Jan 2024 2:23 PM ISTIt is a two-dose vaccine wherein the first dose is administered at 12 months of age and the second dose is given at least 6 months after the first...
Shilpa Medicare gets Germany marketing authorization for Amifampridine Tablets Ruchika Sharma20 Jan 2024 12:30 PM ISTHyderabad: Shilpa Medicare Limited has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National...
Shilpa Medicare gets Code J for Pemetrexed Injection Ruchika Sharma20 Jan 2024 12:30 PM ISTShilpa's - NDA Pemetrexed Injection, is a novel ready-to-use injection which eliminates the need for reconstitution and dilution before administration...
Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types Ruchika Sharma20 Jan 2024 11:24 AM ISTBasel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...
Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market Ruchika Sharma19 Jan 2024 3:30 PM ISTAhmedabad: Zydus Lifesciences Ltd., a global healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered...
With Union Budget 2024, medical devices cos hope for reduction in customs duties Ruchika Sharma19 Jan 2024 2:39 PM ISTNew Delhi: Medical Technology Association of India (MTaI), an association of research-based medical technology companies, has said that...
Lupin bags USFDA nod for hyperuricemia treatment drug Febuxostat Ruchika Sharma19 Jan 2024 1:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
Cabinet approves MoU between India, Ecuador on cooperation in field of Medical Products Regulation Ruchika Sharma19 Jan 2024 12:30 PM ISTNew Delhi: The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, was apprised of a Memorandum of Understanding signed on 07th...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Aurobindo Pharma arm bags CDSCO panel recommendation for grant of marketing authorization of biosimilar trastuzumab Ruchika Sharma18 Jan 2024 3:10 PM ISTHyderabad: In a recent BSE filing, Aurobindo Pharma has announced that CuraTeQ Biologics Pvt. Ltd., a wholly owned subsidiary of the...
USFDA updates Sanofi Dupixent label for atopic dermatitis Ruchika Sharma18 Jan 2024 3:00 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has updated the label for Dupixent (dupilumab) in atopic dermatitis,...
